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Adherence is the primary predictor of treatment success with antiretroviral therapy 
(ART). It is not known whether the use of traditional medicine use predicts non-
adherence to ART. Traditional medicine use has been reported to be common among 
individuals with moderate and advanced HIV disease. There is some data available on 
the prevalence and patterns of African Traditional Medicine (ATM) use in patients 
with HIV/ AIDS. 
 
Aim 
The aim of this cross-sectional study was to describe the prevalence of traditional 
medicine use amongst patients on antiretroviral therapy, aged 18-49 years and to assess 
any association between the use of traditional medicines and adherence to antiretroviral 
therapy in patients seen at Thembalethu Wellness Centre, Northdale Hospital, in 
KwaZulu-Natal, South Africa. 
 
Methods 
Using systematic sampling, 75 HIV-positive patients on antiretroviral therapy were 
selected from the pharmacy queue. Data was collected using primarily a semi-
structured questionnaire with closed and open-ended questions during a face-to-face 
interview. The questionnaire was translated to Zulu. Pre-testing of the questionnaire 
was completed with 5 HIV-infected persons not involved in the study from another 
hospital. Data from closed-ended questions was collected, coded and captured on 
computer using the Microsoft Excel spreadsheet programme then all data was imported 
to SPSS programme for analysis. 
 
Results 
The study findings showed that, of the seven individuals who reported using traditional 
medicines, three (42.9%) also reported to have missed ART doses with one who 
reported missing more than three doses in the preceding month.  Traditional medicines 
were mostly used by African men who followed Christian religion.  
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Traditional medicines were mainly used for cultural purposes specifically; cleansing 
purposes for different reasons. Male sex and the use of African traditional medicines 
were shown to be associated with poor adherence to antiretroviral therapy.  
 
Conclusion 
Although many previous studies have shown that traditional medicines were 
commonly used concomitantly with antiretroviral drugs by HIV positive patients; in 
this study only 9.3% of participants admitted having used traditional medicines in the 
28 days preceding the survey. Participants were more likely to be non-adherent to ART 






This Master of Public Health dissertation is my own work and all primary and 
secondary sources have been appropriately acknowledged. The dissertation has not 
been submitted to any other institution as part of an academic qualification. 
This Dissertation is prepared in partial fulfillment of the requirement of the degree of 
Master of Public Health at the School of Nursing and Public Health, Nelson R 















Department of Public Health Medicine 
Nelson R Mandela School of Medicine 










I wish to express my gratitude and appreciation to the following people: 
 
Mr. Andy Gray, my supervisor, at the School of Medicines and Therapeutics, 
University of KwaZulu-Natal; for his support, encouragement, tolerance and support 
throughout the study. 
 
Mrs Tonya Esterhuizen, biostatistician at the School of Health Sciences, University if 
KwaZulu-Natal, for her guidance with statistical analysis. 
 
Mrs Fikile Nkwanyana, biostatistician at the School of Health Sciences, University if 
KwaZulu-Natal, for her guidance with statistical analysis. 
 
Dr Sibanda, biostatistician at the School of Health Sciences, University if KwaZulu-
Natal, for her guidance with statistical analysis. 
 
The hospital manager at Northdale Hospital in Pietermaritzburg for granting me 
permission to conduct this survey. 
 
Dr Zinhle Makatini at Phidisa Project; for influencing me to join Phidisa project as 
well as encouraging me to study further. 
 
Above all, I thank almighty God for seeing me throughout this journey and for giving 





I dedicate this dissertation to the following people: 
 
 The study participants who volunteered to participate in the study. Thank you 
for your contribution to the health care of South Africa. 
 




ACRONYMS AND ABBREVIATIONS 
ATM  : African Traditional Medicine 
HIV  : Human immunodeficiency virus infection 
AIDS  : Acquired immunodeficiency syndrome 
HAART : Highly Active Antiretroviral Therapy 
ART   : Antiretroviral Therapy 
ARV   : Antiretroviral 
NNRTI  : Non-Nucleoside Reverse Transcriptase Inhibitor 
NRTI  : Nucleoside Reverse Transcriptase Inhibitor 
PI  : Protease Inhibitor 
PLWH  : People Living With HIV 
TCAM  : Traditional, complementary or alternative medicine 
CAT  : Complementary, Alternative and Traditional 
WHO  : World Health Organization 
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CHAPTER 1: INTRODUCTION 
 
1.1 Introduction  
 
South Africa (SA) has one of the highest incidences of HIV/AIDS in the world, and 
has implemented a number of initiatives to combat the pandemic.  One of these is to 
roll out antiretroviral therapy (ART) through its public health facilities, which is 
provided free of charge at most clinics.  However, while it is believed that many of 
those living with HIV also rely on African traditional healers as part of their overall 
health-seeking behavior, there is little empirical evidence to suggest to what extent this 
occurs in those on ART, and how this affects adherence to ART. In particular, it is not 
known whether the use of traditional medicine use predicts non-adherence to ART.  
Such information could inform interventions to enhance adherence counseling and 
strengthen the health care system‟s response to the AIDS pandemic.  
 
As a pharmacist, one of my responsibilities is to ensure safe and optimal use of 
medication therefore this study is relevant to my profession because anything that may 
hinder efficacy of medication such as drug-drug interactions and non-adherence to 
medication needs to be addressed. Pharmacists have played a key role in combating the 
HIV/AIDS epidemic, being the interface between ART prescriptions and patient 
access, their role being to dispense medication and provide information about 
medication.  Their knowledge of medicines formulations makes them key players the 
in health care team. They contribute by monitoring adherence to treatment and the 
emergence of management of adverse effects of the medications they dispense.  A 
pharmacist is often the person that patients approach for advice and with whom they 
discuss their experiences with adverse effects.  It is therefore important for pharmacists 
to understand the factors that affect patient adherence. Their knowledge about 
medicines formulations can assist in understanding the complications associated with 




In an era when people across the globe are seeking health through traditional, 
complementary or alterative medicines, often due to perceived or actual safety 
problems with “orthodox” medicines, greater attention needs to be paid to the 
consequences of the use of such remedies.  
 
This Chapter presents the background to the study, specifically outlining the historical 
background of HIV in SA, and how the epidemic has progressed over the years. It also 
discusses the introduction of ART, the impact that delayed access to ART had in SA, 
and the eventual development of what has become the largest ART programme of any 
country. It briefly touches on concomitant use of ART and traditional medicine and 
further explains the rationale behind doing this study elaborating on its background, 




The early phase of the HIV epidemic in SA was similar to that experienced elsewhere, 
with the initial cases identified in men who have sex with men. After the first case of 
HIV in SA was reported in 1982, prevalence of HIV infection in the general 
heterosexual population remained relatively low at least until 1987 (Abdool Karim and 
Abdool Karim, 2002). In the late 1980s and early 1990s, HIV and AIDS made its way 
onto the national health agenda. Based on annual anonymous antenatal surveys, 
national HIV prevalence rates rose from 0.76% in 1990 to 10.44% in 1995 and 22.4% 
in 2000 (Department of Health,2001).  
 
Anonymous HIV sero-prevalence surveys, conducted among people who attended a 
prenatal clinic in the Hlabisa district of KwaZulu-Natal province, showed a rise in 
prevalence from 4.2% in 1992 to 34.0% in 1999 (Abdool Karim and Abdool Karim, 
2002). Incidence rose from 2.3 per 100 person-years in 1993 to 15.0 per 100 person-
years in 1999. It was estimated that, in 2000, 40% of all adult deaths in SA were due to 
AIDS. The increased deaths in younger persons were clearly demonstrated by the 
change in the ratio of the number of deaths in those aged 15-49 years to the number of 
deaths in those aged over 50 years, between 1990 and 1999/2000. 
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 In males, the ratio increased from 0.66 to 1.00; whereas in females it increased from 
0.31 to 0.78 (Abdool Karim and Abdool Karim, 2002). The South African Health 
Review 2014/15 reported that the total number of patients on ART in the public sector 
exceeded 3 million in April 2015, up from 2.6 million in April 2014. However, the 
National Strategic Plan (NSP) Review raised some serious concerns (NSP, 2012-
2016): it noted that between 2014 and 2015 the number of people on ART grew by 150 
000 in Gauteng, but by only 6 000 in North West, 17 000 in the Free State and 40 000 
in Mpumalanga (Day and Gray, 2015). 
 
South Africa has made great progress in tackling its HIV epidemic during the 
presidency of Jacob Zuma, who was appointed in 2009. The NSP 2007-2011 saw a 
dramatic scaling-up of South Africa's ART programme. The HIV and AIDS 
programme grew significantly since 2010/11, and had been accompanied by a 
reduction in child mortality rates. Reduction in mother-to-child HIV transmission was 
noted from 35 percent to 2.5 percent, increased antiretroviral treatment coverage by an 
average of 500 000 new patients per year, lowered adult mortality rates, an increased 
number of medical male circumcisions, and the maintenance of HIV testing at high 
rates (National Strategic Plan 2014/15-2018/19). In 2011, the UNAIDS World AIDS 
Day Report stated that the sub-Saharan African region had the highest incidence of 
HIV/AIDS, with approximately 68% of those living with HIV at that time being from 
this region, which represented  only 12% of the global population (UNAIDS, 2011). 
The region also accounted for 70% of new HIV infections in 2010, although there was 
a notable decline in the regional rate of new infections. The epidemic continues to be 
most severe in southern Africa, with South Africa having more people living with HIV 
(an estimated 5.6 million) than any other country in the world. Hughes et al. (2012) 
reported that there were approximately 20.8 million individuals in sub-Saharan Africa 
living with HIV. The total number of persons living with HIV in SA increased from an 






1.2.1 Availability of Antiretroviral Therapy 
 
The first antiretroviral (ARV) medicine made available to treat HIV in South Africa 
was zidovudine (variably abbreviated as either ZDV or AZT), which became available 
in 1998. When it was reported that a trial using a short course of ZDV in Thailand had 
reduced the mother-to-child transmission (MTCT) rate by half, this led advocates and 
researchers in South Africa to call for access to such preventive methods (Ijumba et al., 
2003). A far simpler approach, peri-natal provision of nevirapine (NVP), took center 
stage in the debate on access, which was driven mainly by the Treatment Action 
Campaign (TAC), from 1998 to 2001 (Ijumba et al., 2003). 
 
On 19 April 2001, there was a dramatic turn in the legal challenge faced by Nelson 
Mandela and his government against lawyers acting for South Africa‟s Pharmaceutical 
Manufacturers‟ Association (PMA), which represented 40 multinational 
pharmaceutical companies in the Pretoria High Court. PMA‟s lawyers had informed 
the judge that it was unconditionally withdrawing its case against the country‟s 
government and that it would bear all costs in the matter (Mbali, 2013). The Mandela 
administration was then free to implement the Medicines and Related Substances 
Amendment Act (Act 90 of 1997), in order to enable wider access to cheaper generic 
and imported patented drugs.  Moreover, this successful campaign against the court 
case had a meaningful impact for poor patients in developing countries and 
successfully altered the politics of ARV pricing globally. Under voluntary licensing 
provisions, or in countries where patents were either not in place or not enforced, 
improved access to lower-priced generic ARVs facilitated a significant widening of 
global access to this treatment. This was particularly notable in sub-Saharan Africa, 
after the creation of new financing mechanisms such as the Global Fund to Fight 
AIDS, TB and Malaria (GFATM) and the US President‟s Emergency Fund for AIDS 
relief (PEPFAR).  In addition, the pharmaceutical industry introduced substantial 
reductions in the prices of certain branded ARVs in some settings (Mbali, 2013).  
 
Since 2004, ARVs have been made available at South Africa public health facilities at 
no charge for those living with HIV who met eligibility criteria.  
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Over time the CD4 threshold for eligibility to ART has been increased from 200 per 
ml, to 350, and now to 500 (NDOH, 2014). The most recent of these changes was 
made by the Minister of Health, Dr. Aaron Motsoaledi, during his budget speech in 
July 2014. A move to a test-and-treat approach, removing the CD4 threshold is widely 
expected, in line with the most recent World Health Organization guidelines (WHO, 
2013).  
 
UNAIDS (2014) reported that 2.3 million people gained access to ART in 2013, which 
would bring the global number of people accessing ART to nearly 13 million.  
While UNAIDS projected that by July 2014 as many as 13 950 296 people would be 
able to  access ART, the report further showed that 19 million of the 35 million people 
living with HIV did not know that they were infected. UNAIDS further reported that 
research showed that in sub-Saharan Africa 76% of people on ART have achieved viral 
suppression, and were unlikely to transmit the virus to their sexual partners (UNAIDS, 
2014).  As of June 2015, 15.8 million people living with HIV were accessing ART, up 
from 13.6 million in June 2014. By the end of 2014, 36.9 million people globally were 
living with HIV, 2 million people became newly infected with HIV and 1.2 million 
people died from AIDS-related illnesses (UNAIDS, 2015). UNAIDS further reported 
that 41% of all adults living with HIV were accessing treatment in 2014, up from 23% 
in 2010. However, only 32% of all children living with HIV were accessing treatment 
in 2014, up from 14% in 2010. In 2014, 73% of pregnant women living with HIV had 
access to ARVs to prevent transmission of HIV to their babies and new HIV infections 
among children were reduced by 58% between 2000 and 2014. 
 
It cannot be over-emphasized that correct adherence to ART is essential for good 
treatment outcomes, as it can prevent both the emergence of drug resistance and 
continued immunosuppression (Naidoo et al., 2013). 
 
1.2.2 Global use of traditional medicine 
 
In some Asian and African countries, it has been claimed that as many as 80% of the 
population depend on traditional medicine for primary health care (WHO, 2008).  
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In addition the WHO (2008) reported that, in many developed countries, surveys have 
shown that 70% to 80% of the population have used some form of alternative or 
complementary medicine. Herbal medicines were the most popular form of traditional 
medicine, and form a highly lucrative part of the international market for such 
products. Annual revenues in Western Europe reached US$5 billion in 2003-2004. In 
China, sales of Traditional Chinese Medicine (TCM) products totalled US$14 billion 
in 2007 (WHO, 2008). 
 
1.2.3 National use of traditional medicine  
 
The extent of traditional medicines use in South Africa has not been well characterised, 
particularly in patients living with HIV. There are some data available on the extent of 
reliance on traditional healers as the first pot of call for households experiencing illness 
of injury, from each edition of the Statistics South Africa General Household Survey 
(Statistics South Africa, 2015), but these are not specific to the population living with 
HIV. In the General Household Surveys, the percentage of households that would first 
consult a traditional healer has consistently been very low, below 1%. That may be an 
under-estimate of the extent of use of traditional medicines. Studies undertaken outside 
South Africa have reported that between 15% and 79% of people living with HIV 
utilise traditional medicine, representing a higher rate of utilisation than that shown in 
people with other serious illnesses (Puoane et al., 2012). 
 
1.2.4 Concomitant use of Antiretroviral Therapy and African Traditional 
Medicine  
A review of reports on the use of African Traditional Medicine amongst people living 
with HIV, showed that  there was evidence to suggest concomitant use of ARVs and 
traditional remedies, and that the reasons for such use included perceived  alignment 
with cultural and/ or religious beliefs, use as a safe alternative to ARVs, for synergism 
with ARVs, to alleviate the adverse effects of ARVs, as a general way to promote 
health and quality of life and to treat HIV-related fatigue, nausea and pain (Muller and 
Kanfer, 2011). However, very few patients informed their health care providers of their 
use of traditional medicines or their reasons for using such products.  
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Malangu (2007) reported that that approximately 75% of HIV-infected patients in 
South Africa also took some form of complementary or ATM at the same time. 
Mudzviti et al. (2012) reported that the majority of patients (98%) in their study, which 
was conducted at a Family Care Centre ART clinic in Zimbabwe, were taking at least 
one indigenous herbal remedy together with their ART regimen. 
 
In South Africa, it was claimed that 80-90% of Black African patients use both the 
traditional healers and the biomedical personnel‟s services out of the need for the best 
healing therapy to fulfill their health needs (Pinkoane et al., 2012). However; in a study 
conducted in Pretoria on self-reported use of traditional medicines by patients on ART, 
only 8.9% reported using a limited range of over-the-counter products as well as those 
from traditional medicine practices (Malangu, 2007).  
 
The studies by both Pinkoane et al. (2012) and Mudzviti et al. (2012) showed results 
that were almost similar, but the results provided by Malangu (2007) are quite 
different. This supports the need to further examine the extent of use of ATM in 
patients receiving ART in South Africa.  
 
1.2.5 National Policy and Regulation for African Traditional Medicine 
 
Regulating traditional medicine products, practices and practitioners is difficult due to 
variations in definitions and categorisations of traditional medicine therapies. A single 
herbal product could be defined as food, a dietary supplement or herbal medicine, 
depending on the country. This disparity in regulations at the national level has 
implications for international access and distribution of product (WHO, 2008). In a 
briefing held by South African Department of Health on „Institutionalisation of the Use 
of Traditional Medicine‟, it was mentioned that the Medicines Control Council (MCC) 
had established an African Traditional Medicines Committee to evaluate traditional 
medicines, with a view to facilitating their registration. In that briefing an African 
medicine clinical trials committee was also announced, to develop guidelines for 
managing such clinical trials (Minister of Health, 2008). A ministerial task team would 
investigate the functioning of these bodies with a view to improving their efficiency 
and relevance.  
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A Draft National Policy on African Traditional Medicine in South Africa has been 
issued, and is designed to provide a framework for the institutionalization of African 
Traditional Medicine in the South African system (Minister of Health, 2008).  
 
In May 2014, the President issued a promulgation notice bringing some sections of the 
Traditional Health Practitioners Act (Act 22 of 2007) into operation (Gray and Vawda, 
2015). Progress in this regard had been slow as the planned Traditional Health 
Practitioners Council faced serious challenges, to initial set-up funding, also in relation 
to contacting and recording the large number of traditional health practitioners of 
various categories who were already in practice (Gray and Vawda, 2015). 
 
1.3 Problem Statement 
 
Despite the effectiveness of ART being documented and having changed the 
progression of the disease in South Africa, many people in the country, and other 
developing countries, also seek treatment from traditional healers. The extent of use of 
ATM in patients on ART is not well documented, and there is inconclusive evidence 
on how its concurrent use impacts on adherence to ART.  This information is 
important, as a lack of adherence has implications for the ongoing effectiveness of the 
medication as well as the wellbeing of those who do not take it regularly.  
 
1.4 Research Question 
 
What is the prevalence of ATM use among patients on ART at the Thembalethu 
Wellness Centre, Northdale Hospital, and is there any association between the use of 
ATM and adherence to ART. 
 
1.5 Aim and Objectives  
 
The broad aim of this study is to contribute to the understanding of the delivery of 
ART in an African setting, and thus to the development of appropriate interventions 




The study had the following objectives: 
1. To describe the prevalence of ATM use in study participants on ART provided 
by Northdale Hospital. 
2. To identify which ATMs are most commonly used by study participants on 
ART. 
3. To describe the study participants‟ perceptions about the effectiveness and 
safety of ATMs in this setting. 
4. To investigate factors associated with the use of ATMs by study participants on 
ART.  
5. To compare the level of adherence to ART amongst users and non-users of 
ATMs, as recorded by the Northdale ARV pharmacy. 
6. To make recommendations on appropriate patient care; including advice on the 
concurrent use of ATMs by those on ART. 
1.6 Definition of terms 
 
Non-adherence: as missing three or more doses of antiretroviral treatment in a period 
of one month.  
Traditional medicine: According to WHO, traditional medicine includes “diverse 
health practices, approaches, knowledge and beliefs incorporating plant, animal 
and/or mineral based medicines, spiritual therapies, manual techniques and 
exercises applied singularly or in combination to maintain well-being, as well as to 
treat, diagnose or prevent illness” (WHO, 2002).  
African traditional medicine: a locally developed definition is that “in South Africa, 
most people associate traditional medicine with the herbs, remedies (or muthi) and 
advice imparted by isangoma or izinyanga– traditional healers from African 
indigenous groups – and with strong spiritual components” (Richter, 2003). 
Antiretroviral therapy (ART): these are used to treat infection by retroviruses, 
primarily HIV. Therapy with antiretroviral medicines constitutes ART. When 
several such medicines, typically three, are taken in combination, the approach is 




1.7 Study Outline  
 
The study is presented in the following five chapters: 
Chapter 2. Literature Review: this chapter reviews the literature on the recent findings 
on ATM use among people living with HIV who have started taking ART.  
Chapter 3. Methodology: this chapter describes the research study design, the method 
that was used to gather and analyze the data.  
Chapter 4. Results: this chapter provides the presentation of the results of the study 
findings with respect to the first five Objectives.  
Chapter 5. Discussion: this chapter discusses the results presented in Chapter 4, 
specifically with respect to the study Objectives. . 
Chapter 6. Conclusion: this chapter answers the research questions and establishes to 
what extent the Aim has been met. It outlines the study limitations and makes 
recommendations in line with Objective 6. It outlines the significance of the findings 
and identifies gaps in knowledge that require further research. 




This chapter presents a review of traditional medicine use among people living with 
HIV and who take antiretroviral therapy (ART). It explores ART and adherence in 
general, the reasons for using traditional medicines, factors that could be associated 
with the decision to consult with a traditional healer, the prevalence of traditional 
medicines use in patients on ART, the concomitant use of traditional medicine and 








2.2 ART and adherence in general 
 
A number of researchers have described the challenges of adherence to medication and 
to antiretrovirals (ARVs) in particular, with Chaiyachati et al. (2014), in a study to 
systematically review interventions to improve adherence to antiretroviral therapy, 
defining adherence as the extent to which a person uses medication according to 
medical recommendations, inclusive of timing, dosing, and consistency. In their study, 
Reda and Biadgilign (2011) defined adherence as taking medications or interventions 
correctly according to prescription whereas Owen-Smith et al. (2007) classified their 
participants as non-adherent if they reported missing any doses of their antiretroviral 
medication in the 30 days preceding the baseline assessment. Adherence to 
antiretroviral therapy (ART) has been a challenge in Africa and globally, as shown by 
several studies reviewed. However, despite concerns that patients in less-developed 
settings would be more likely to be non-adherent to ART; a review by Reda et al. 
(2011) indicated that sub-Saharan African patients have the same or higher adherence 
levels as those in developed countries. A pooled result of a systematic review looking 
at adherence to ART in India showed a 70% adherence rate (Mhaskar et al. 2013). 
Mathes et al. (2014) performed a systematic review to evaluate estimates of ART 
adherence in Sub-Saharan Africa and North America, with the former being 55% (95% 
CI: 49%-62%) and the latter 77% (95% CI: 68%-85%). They concluded that favorable 
levels of adherence in sub-Saharan African settings could be achieved, while 
adherence in North America remained a concern. 
 
2.2.1 The importance of adherence for clinical outcomes  
 
The World Health Organization (WHO) has explained clearly that “strict adherence to 
ART is key to sustained HIV suppression, reduced risk of resistance, improved overall 
health, quality of life and survival, as well as decreased risk of transmission” (WHO, 
2003). Adherence to antiretroviral medication to treat HIV is critical, both to maximize 
efficacy and to minimize the emergence of drug resistance (Peltzer et al., 2010). 
Adherence is the primary predictor of treatment success with ART, with the 
inconsistent use of ART being problematic, given its association with both loss of viral 
suppression and the emergence of drug resistance.  
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Nachega et al. (2012) systematically reviewed ART adherence rates during pregnancy 
and postpartum in high-, middle- and low-income countries and stated that virologic 
and clinical success depended on good adherence, with poor adherence enabling the 
virus to quickly develop therapy-limiting drug resistance.  
 
Even moderate non-adherence to ART has been reported to have significant primary 
and secondary negative consequences, such as the risk of further compromised cell-
mediated immune function leading to opportunistic infections and the development of 
resistant viral strains (Steele et al., 2001). According to studies on adherence that were 
reported by Reda and Biadgilign (2011), ART regimens require 70-90% adherence to 
be effective. However this seems lower than that routinely stated, as the most 
commonly quoted figure is that 95% adherence is required (Emamzadeh-Fard et al., 
2012). A high level of adherence to ART is important for long-term viral suppression 
to delay progression to AIDS. 
 
2.2.2 Challenges in measuring adherence 
 
The accurate measurement of adherence to antiretroviral therapy is a requirement for 
HIV care provision, but is also key to research into interventions aimed at maximizing 
adherence.  
 
Chaiyachati et al. (2014), in a study to systematically review global evidence on 
interventions to improve adherence to antiretroviral therapy from randomized clinical 
trials, found that more than 20 studies had tested the effectiveness of each of the 
following interventions: cognitive-behavioural interventions, education, treatment 
supporters, directly observed therapy and active adherence reminder devices such as 
mobile telephone text messages. There was strong evidence that all five interventions 
could significantly increase ART adherence in some settings, but each intervention had 






Reda and Biadgilign (2011) reviewed articles involving HIV-positive individuals that 
measured adherence to ART and its predictors in the last decade in Africa, and found 
different methods for measuring adherence that included direct methods, such as 
biologic markers and body fluid assays, or indirect methods, such as self-report, 
interview, pill counts, pharmacy records, computerised medication caps, and viral load 
monitoring. The studies indicated that self-reports correlated well with both viral load 
and clinical outcomes, and that, as expected, the use of computerised medication caps 
was reliable and was less prone to respondent bias. 
 
The definition of what constitutes adherent behaviour has varied though. In a 
systematic review published in 2011, 12 papers and four abstracts defined adherence as 
taking 95% or more doses during the measurement period, which ranged from two 
days to six months (Rachlis et al., 2011). However, five studies defined adherence as 
being 100%, three studies indicated 90%, while the median adherence proportions in 
cross-sectional studies were 74.3% (range 25-88%) for published studies alone and 
73.6% when three conference abstracts were added. The median adherence levels 
among the three longitudinal studies included was 58.1%, but this increased to 70% 
after the three conference abstracts were added. The overall range differed little from 
the cross-sectional studies reported (37-88%) (Rachlis et al., 2011). 
 
The most commonly used target is that patients should take 95% of doses as instructed, 
on time and in the correct manner. However, the means to measure adherence range 
from the simple (recall or pill counts) to the highly technological (computerised 
medication container caps). If well-conducted, self-report and recall can be used as a 
reasonable measure of adherence in routine clinical care. 
 
2.2.3 Determinants of treatment adherence – factors associated with poor 
adherence 
 
Studies have reported many factors as being associated with poor adherence to ART. A 
systematic review in Asian developing countries (Wasti et al., 2012) reported several 
factors that hinder adherence to ART, namely:  
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 patient-related factors (forgetting to take medication on time, being too busy, 
being away from home, not understanding the treatment, feeling depressed or 
overwhelmed, lack of motivation); 
 socio-cultural factors (stigma and discrimination, fear of being recognized at 
living with HIV or on ART, fear of disclosure, lack of family support); 
 beliefs about medication (did not think pills were needed, pills were a burden, 
taking pills for a long period); and 
 medication side effect, financial difficulties and health-system factors. 
 
Lubega et al. (2010) conducted a study in a resource-poor setting in eastern Uganda to 
explore reasons for drop-out from pre-ARV care, and found that inadequate 
counseling, competition from traditional or spiritual healers, transportation costs, 
waiting time, lack of incentives and gender inequality were commonly cited. A study 
in adult patients of African-American descent, to investigate adherence to HIV 
treatment and retention in care, found that central nervous system side effects such as 
dizziness, insomnia, depression and other psychiatric illnesses, particularly in those 
taking efavirenz, strongly influenced adherence (Snow et al., 2010).  
 
In addition, Snow et al. (2010) noted other factors, such as unemployment, lack of 
effective social support networks, unstable living conditions, incarceration, non-
disclosure of HIV status, active alcohol use, patient-level socioeconomic, income and 
education, as being important. Data from rural Mozambique showed that perceived 
challenges by community participants and health care workers included the inability to 
afford food in sufficient quantity or quality, lack of transportation and stigma (Groh et 
al., 2011). A study of 686 patients at two large ART centres in the Ugandan capital, 
Kampala, found that cost was the most significant factor causing discontinuation of 
therapy, followed by negative medication-related side-effects and poor medication 
supply (Kiguba et al., 2007).  
 
A study in South Africa by Maqudu et al. (2010) explored the influence of baseline 
factors on first month adherence to ART among adult patients. During the first month 
of ART, 79% of patients were adherent, but this was negatively associated with a 
higher baseline CD4 count.  
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In other words, those patients who were more ill were more likely to adhere to 
treatment. A systematic review that examined adherence to ART in India reported that 
50% of studies showed that the cost of medication was an obstacle to treatment 
adherence, with 25% reporting lack of access to medication, and 12% citing adverse 
events (Mhaskar et al. 2013). 
 
Overall, therefore, there is a consistent thread running through the available evidence, 
from resource-constrained settings in particular. While high levels of adherence are 
possible in such settings, a number of factors need to be addressed in order to 
maximize adherence. These include the avoidance of ART regimens associated with 
frequent toxicity, careful counseling on those adverse effects that are time-limited in 
nature (such as the neuropsychiatric effects associated with efavirenz), but also careful 
attention to such barriers as cost, stigma and poor supply chain management. However, 
there are studies from African settings that have pointed to the potential for 
competition between biomedical approaches and those advocated by traditional or 
spiritual healers who may be consulted by patients on ART. 
 
2.2.4 Measures to improve adherence 
 
Studies reviewed indicate that many measures can be taken to improve adherence to 
ART. Mathes et al. (2014) performed a systematic review to explore estimates of ART 
adherence impacts in Sub-Saharan Africa and North America and found that short 
message service (sms) interventions showed a statistically significant effect on 
adherence (95% CI -0.17 to -0.03), and that modified directly observed therapy (DOT) 
showed a significant effect on mortality (relative risk 0.75; 95% CI 0.44 to 1.26). A 
systematic review by Wasti et al. (2012) that explored the factors influencing 
adherence to ART in Asian developing countries, identified facilitators or motivators 
of adherence to be social support from family and friends, self-efficacy, willingness to 
live longer, improved overall health, financial assistance, using electronic reminders, 
obligation to live for family, good relationship with care providers, and worries 




On the basis of the study conducted by Groh et al. (2011), which explored barriers to 
ART adherence in rural Mozambique, it was recommended that several interventions, 
such as providing food supplementation to patients enrolled in care, integrating 
traditional healers and religious healers into the biomedical system, and engaging 
expert patients to mentor those initiating ART, should be used to address those 
barriers. 
 
As indicated previously, the available data have identified a range of adherence-
promoting interventions that have been shown to be effective in resource-poor 
environments. Of particular relevance to the current study, data from Mozambique, a 
neighbouring African county, has underlined the need to integrate traditional and 
religious healers into the biomedical system, in order to address their potential impact 
on ART adherence. 
 
2.3 ART and the use of traditional, complementary or alternative 
medicines 
 
In settings where the use of traditional, complementary or alternative medicines is 
prevalent, it would be expected that patients on ART would also use these medicines. 
Lubega et al. (2010) showed that the reported reasons for drop-out from pre-ARV care 
in a resource poor-resource setting in eastern Uganda included that the traditional 
healers provided other forms of pre-ARV services in direct competition to the formal 
health providers. It appeared that traditional healers were undermining pre-ARV care, 
as they provided alternative services. Owen-Smith et al. (2007) recommended that 
health care providers and patients should have explicit dialogues about how to 
effectively integrate traditional practices into biomedical treatment regimens so that the 







2.3.1 Reasons for consulting traditional health practitioners 
 
Traditional medicine has been reported to be widely used in African countries, 
including South Africa. The WHO reported that between 60 and 70% of Africans 
approach traditional healers as their first line of health care (World Health 
Organization, 2002). According to the WHO (2008) in some Asian and African 
countries, it has been claimed that as many as 80% of the population depend on 
traditional medicine for primary health care. However, these figures have also been 
questioned and routine data collected annually by the Statistics South Africa (Stats SA) 
service offer a different picture. For example, the 2015 General Household Survey 
found that just 0.5% of South Africans reported consulting traditional healers first 
when household members fall ill or have accidents (Stats SA General Household 
Survey, 2016). That figure has remained in the range of 0.1 to 0.5% in annual surveys 
conducted between 2004 and 2015. However, few data are available on the prevalence 
and patterns of African traditional medicine (ATM) use specifically in patients living 
with HIV or receiving ART.  
 
A cross-sectional study in Zimbabwe to determine the impact of herbal drug use on 
adverse drug reactions in patients on ART found that the major reasons for use of 
African traditional medicines (ATMs) were perceived additional efficacy, improved 
quality of life, and having control over the disease (Mudzviti et al., 2012). Truter 
(2007) has listed the reasons that have been given by people for including traditional 
healing options as follows:  
 “know healers quite well; 
 visits are not only for health but also for other problems; 
 belief that illness arises from supernatural causes and indicates the displeasure of 
ancestral gods or evil spirits or is the effect of black magic; 
 a firmly and irrevocably established health care system throughout the whole 
continent of Africa; 
 forms part of the culture and custom; 
 traditional medicine and the various African cultures go together, they cannot be 
separated; 
 lack of satisfaction with treatment; 
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 lack of trust in the ability of Western medical practitioners to effectively treat 
psychosocial problems; 
 lack of knowledge of Western medical practitioners to treat culture-bound 
syndromes”. 
In a review of reports on the use of ATM amongst those living with HIV, the reasons 
for their use included: alignment with cultural and/ or religious beliefs, a safe 
alternative to ARVs, their synergism with ARVs, to alleviate the adverse effects of 
ARVs, as a general way to promote health and quality of life, and to treat HIV-related 
fatigue, nausea and pain (Muller and Kanfer, 2011). Simon et al. (2010) aimed to 
identify behavioral aspects of ART preparedness that could be targeted for local 
interventions to enhance treatment outcomes, and found that 73% of all respondents 
thought that ARVs worked better than traditional medicine, 56% thought it was not 
safe to use ART together with traditional medicine, and only 10 % reported that 
traditional medicine treats HIV/AIDS. Namuddu et al. (2011) examined the prevalence 
and factors associated with ATM use among patients on ART in Uganda, and found 
that the most stated reasons for traditional medicine use were to reduce fever (67.4%) 
and treat coughs (65.2%).  
 
In a study that aimed at assessing the use of traditional herbal medicine by AIDS 
patients in Kabarole District, western Uganda, 137 AIDS patients were selected from 
outpatient departments of three hospitals (Langlois-Klassen et al., 2007). A 
questionnaire-based interview found that, overall, 63.5% of AIDS patients had used 
herbal medicine after HIV diagnosis, while same-day herbal medicine and 
pharmaceutical drugs were reported by 32.8% of AIDS patients. Patterns of traditional 
herbal medicine use were quite similar between those on ART and those who received 
supportive therapy only. The primary conclusion reached was that AIDS outpatients 
commonly use herbal medicine in that setting. Specifically in South Africa, Babb et al. 
(2007) investigated the use of traditional medicines among HIV-infected individuals 
attending a workplace clinic where an ART programme had recently been launched. 
Among 44 interviewees (all male, mean age 42 years), 30 had started ART. Of the 
respondents 37/44 (84%) reported ever using traditional medicine, and 14/44 (32%) 
were current users.  
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Among "ever-users", most obtained traditional medicine from a traditional healer 
(42%) or herbalist (26%), but 21% obtained these products from their own yards or 
fields. Frequently-used products included African potato plant (Hypoxis rooperi) and 
kgala (Aloe vera). Interviewees currently using traditional medicines felt that these 
remedies made their health "better" (12/14, 86%) or "much better" (2/14, 14%), and 
none felt that they had side effects. In this small study, 7/14 (50%) current users 
reported that they were using ATMs specifically for HIV (Babb et al., 2007). Among 
23 individuals who had discontinued traditional medicine use, six (26%) reported that 
this followed advice from health care staff when they started ART. The researchers 
found that the cost of ATMs varied greatly, depending on the type and source of 
remedy used. 
 
The common thread in these studies from an African setting is that ATMs are trusted 
and considered to be safe, but are considered to be complementary to ART, not 
necessarily as a substitute for ART (Babb et al., 2007, Langlois-Klassen et al., 2007, 
Namuddu et al., 2011). However, the patterns are not that different in non-African 
settings. An exploratory study of alternative medicine prevalence and user 
characteristics in a sample of Dutch gay men revealed that 71% of all respondents 
reported to have used at least one form of alternative treatment since learning of their 
HIV serostatus (Knippels and Weiss, 2000). Of this sample, 62.9% reported having 
used food supplements, 17.1% traditional medicines, 15.7% massage/yoga/meditation/ 
imagery, 21.4% homeopathy and 5.7% acupuncture. 
 
2.3.2 Factors associated with consulting a traditional healer 
 
The subjective reasons for using ATMs may differ from the objective factors 
associated with their use. As noted above, Knippels and Weiss (2000) conducted an 
exploratory study of alternative medicine prevalence and user characteristics in a 
sample of Dutch gay men, and found that symptomatic individuals were more likely to 
use alternative medicine. Their regression model further suggested that individuals 
who were more likely to use alternative medicine were those in whom levels of HIV-
related pain were low or absent, and those who used active coping strategies in 
response to HIV-related problems and emotion-focused coping mechanisms.  
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In an African setting, Taylor et al. (2008) examined changes in self-reported health 
status resulting from accessing either traditional African care (61%) or western medical 
care (39%) over one month in presumptively HIV-seropositive patients residing in 
Chipinge, Zimbabwe, a small farming district. They found that patients who received 
traditional African care versus western medical care sites demonstrated a significantly 
greater improvement across the majority of quality of life dimensions, such as overall 
function, disclosure worries, life satisfaction, general health perceptions, physical 
function, pain, mental health, health distress and provider trust. However, it must be 
emphasized that these were not confirmed patients with symptomatic HIV disease or 
on ART. Also from Zimbabwe, Lubinga et al. (2012) examined factors associated with 
the concomitant use of ATM and ART in patients at Mbarara Hospital, and found that 
the factors identified included time since start of ART, perceived quality of service at 
clinic, ART regimen, number of attributes of ART informed about, number of ART 
side effects reported, and self-perceived health status. 
 
In a study among patients on ART in Uganda, single individuals were more likely to 
use traditional medicine compared to married persons (Namuddu et al., 2011). 
According to this source, those who were more likely to use traditional medicine were 
younger than 38 years (P=0.002), reported side effects from ART and had been on 
ART for less than 4 years. 
 
Participants in a qualitative study conducted in Uganda with the aim to investigate the 
role of HIV testing, counselling and treatment in coping with HIV/AIDS, explained 
that the early mystic nature of HIV/AIDS caused many to believe it was witchcraft, 
and that it was this belief that led them to seek traditional and spiritual help rather than 
medical treatment (Nyanzi-Wakholi et al., 2009). However, although traditional 
medicines were commended for their nutritional value and traditional healing 
physically, spiritually and emotionally, traditional medicines were condemned for not 
having proper dosages, expiry dates and hygienic processes of production. 
In South Africa, Peltzer et al. (2010) conducted a study in three public hospitals in 




They found that, overall, ATM use was associated with younger ages, higher 
educational level, lower self-reported quality of life, missing ART doses in order to 
avoid side effects, better self-reported HIV disease, and lower health care information 
involvement score. 
2.3.3 Prevalence and concomitant use of traditional medicines in patients 
on ART 
 
If the WHO figures are to be accepted, then there is no reason to believe that any less 
than 60% of African patients on ART would be using ATM, perhaps at the same time. 
However, if the results of the Stats SA General Household Survey are accepted, then as 
few as 1% of African patients on ART might be using ATMs at the same time. Data 
from Uganda showed that 33.7% (95% CI: 33.38-34.02) of patients on ART were 
using ATM (Namuddu et al., 2011). A study in Kabarole district, western Uganda, 
found that 38% of HIV-positive patients used ATMs and ARVs at the same time to 
manage their HIV infection (Langlois-Klassen et al., 2007). 
 
Locally, a cross-sectional survey among young adults of unknown HIV serostatus in 
Tugela Ferry, KwaZulu-Natal was conducted in order to identify behavioral aspects of 
ART preparedness that could be targeted by local interventions in order to enhance 
ART outcomes (Simon et al., 2010). It was found that almost three-quarters (73%) of 
all respondents thought that ART works better than traditional medicine, while 56% 
thought that it is not safe to use ART with traditional medicine. Only 10% reported that 
traditional medicine or spirits can cure or treat HIV/AIDS, and 5% believed that any of 
the government-advocated folk remedies cured or treated HIV/AIDS. Although only a 
minority of the respondents in this study reported visiting traditional healers, of these 
50% perceived that their healer would recommend traditional medicine only, 24% 
ART only and 25% both, and 26% thought it would be hard to stop using traditional 
medicines. However, cross-sectional studies can also be misleading. A study conducted 
in three public hospitals in Kwazulu-Natal found that ATM use significantly declined 
from 36.6% prior to ART initiation to 7.9% after being on treatment for six months 




The same group also reported that ATM use declined from the initial 36.6% prior to 
ART, to 8% after six months, 4.1% after 12 months and 0.6% after 20 months on ART 
(Peltzer et al., 2011). What is significant here is not only the effect of ART on self-
reported ATM use, but the changes over time. 
 
Theoretically, given the paucity of information about potential interactions between 
poorly characterised ATMs and ARVs, the concomitant use of these medicines should 
be viewed with caution. In most cases, clinicians and pharmacists would urge patients 
on ART not to use anything else without consultation. According to Mudzviti et al. 
(2012), the impact of co-administration of traditional herbal medicine with orthodox 
medicine has not yet been fully evaluated. Researchers in a study that looked at 
potential pharmacokinetic interactions between ART mentioned that there was 
evidence from different surveys that some HIV-positive patients also used ARVs and 
herbal remedies concomitantly, often without the knowledge of their health care 
providers (Muller and Kanfer, 2011). 
 
2.4 The impact of traditional medicine use on ART adherence 
 
Apart from the potential for drug-drug interactions between ATM and ARVs, there are 
concerns about the potential for negative effects on ART adherence when patients use 
ATM at the same time. HIV-positive Ugandans were believed to be twice as likely to 
quit ART if they also use traditional herbal medicine (Anon, 2007). In this news piece, 
Dr Ronald Kiguba from Makerere University, stated that the integration of traditional 
healers into modern medical practice needed to be handled more cautiously: “If these 
healers can be trained properly in HIV care then they can be a new avenue for clinical 
care. It's not easy, but the alternative is we continue to lose patients.” Owen-Smith et 
al. (2007) investigated whether traditional medicine use impacted on adherence to 
prescribed ARV antiretroviral regimens among HIV-positive women, mostly African-
American in Alabama and Georgia, with approximately 60% of participants reporting 
the use of some form of traditional medicine. Women using traditional medicine, 
relative to non-traditional medicine users, were 1.69 times more likely to report 
missing ART doses in the last 30 days (95% CI: 1.02-2.80; P=.041), even after 
adjusting for age, education, race, religion and income. 
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A study of traditional medicine among patients on ART at Mbarara Hospital in 
Zimbabwe, examined factors associated with their concomitant use and their impact on 
ART adherence and found that overall 19.5% (n=65) of participants had poor 
adherence (Lubinga et al., 2012). Of these, 19.4% (n=30) were concomitantly using 
traditional medicines but concomitant use of traditional medicine and ART was not 
associated with poor ART adherence on bivariate analysis (OR 0.99; 95% CI: 0.47-
1.53). The only prospectively collected data from South Africa showed that 
concomitant use of herbal treatment for HIV was associated with reduced ARV 
adherence among attendees at 3 public sector hospitals in KwaZulu-Natal (Peltzer et 
al., 2010). The authors recommended that patients‟ use of traditional medicine should 




It is clearly evident from the available literature that ATM has been reported to be 
widely used in Africa settings, as is the case with traditional, complementary and 
alternative medicines in many other countries. The reasons for the use of traditional 
medicines vary considerably, but reflect cultural beliefs, religious beliefs, a desire for 
the alleviation of ART side effects, a desire to achieve additional efficacy in 
suppressing the virus and managing HIV disease, and a desire for improvement in 
quality of life. However, several studies have shown that concurrent use of traditional 
medicine may interfere with adherence to ART. 
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This study examined the extent of use of traditional medicines in patients on 
antiretroviral therapy (ART), and how this impacted on adherence to ART. This 
chapter details the type of research, the study location, study population and sample. It 
details the data collection tools with respect to the study Objectives, the pilot study, 
how bias was addressed, and the data collection process.  It further describes how the 
data were managed, how the qualitative and quantitative data for the various 
Objectives was analysed, as well as what ethical issues were addressed, specifically 
how the participants‟ confidentiality was maintained and their rights protected. 
 
3.2 Type of research 
 
This study can be broadly categorized as epidemiological research using a descriptive, 
cross-sectional design with systematic sampling. Descriptive research is used to 
describe characteristics, such as the size of a problem, the demographic, geographic or 
distribution of a population being studied. Cross-sectional studies involve the analysis 
of data collected from a population at one specific point in time and therefore; offer a 
cost-effective way to gather information from many people in a short period of time.  
 
3.3 Study location 
 
The study was conducted on patients receiving ambulatory ART at the Thembalethu 
Wellness Centre, Northdale Hospital, a district level referral facility in 
Pietermaritzburg, the capital city of KwaZulu-Natal province. The facility is located 
within the uMgungundlovu District Municipality (DC22), and specifically in the 
Msunduzi Local Municipality (KZN225).  
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In 2012, the estimated total population of the Msunduzi Local Municipality was 639 
575 people (National Department of Health, 2012).  
 
Free ART services were provided to public sector dependent patients who were living 
with HIV at the hospital‟s Thembalethu Wellness Centre in accordance with the South 
African National Strategic Plan for HIV, STIs and TB (2012-2016) (National 
Department of Health, 2012), and in alignment with the applicable Standard Treatment 
Guidelines that were in place at that time (National Department of Health, 2010). 
 
3.4 Study population 
 
The population of interest were patients receiving ART from the Thembalethu 
Wellness Centre in Northdale Hospital, Pietermaritzburg. This health facility served 
people from all race groups who reside in the suburbs surrounding the hospital, as well 
as nearby townships and rural areas. Patients were referred from primary health care 
facilities and were required to visit the clinic monthly once ART has been initiated to 
receive treatment.  The patients seen at the facility were those who were not 
beneficiaries of a private medical scheme and who could not afford private health care 
services. In addition, many people of all ages who attended such public sector health 
facilities relied on social grants as an important source of income (de Paoli et al., 
2012), thus indicating a strong reliance on comprehensive public sector services. The 
clinic was open daily, except Saturday and Sunday, and was serviced by medical 
officers as well as nurses. In 2015, the public health sector employed 13 656 medical 
practitioners, 4 986 medical specialists, 68 105 professional nurses and 4 970 
pharmacists (Day and Gray, 2015). Only in the case of professional nurses did this 
represent more than 50% of the health professionals in that category registered by the 
relevant statutory health council. 
 
3.5 Sample size 
 
Systematic sampling was used to recruit the study population, this entailing that every 
3rd participant from the pharmacy queue was selected. 
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 Based on the study done by Langlois-Klassen et al. (2007), where it was shown that 
63.5% of AIDS patients in a Western Ugandan district had used herbal medicine after 
HIV diagnosis, the assumption was made that the same proportion of the local sample 
would be traditional medicine users. A sample size of 49 participants who were 
prescribed ART was initially considered to be adequate to provide an 80% power to 
detect a difference between those did and did not used traditional medicines (TMs) of 
0.40. However, in order to increase the validity of the study, the sample size was 
increased to 75 and to account for possible refusals, a total of 80 patients were 
approached for interviews. Within this study sample on ART, it was assumed that 25% 
of patients would be using TMs, and 75% would not be using such medicines.  
 
The following inclusion criteria were applied in selecting the participants: 
 aged 18-49 years; 
 those who had been on ART for at least one year; 
 both males and females;  
 those who were able and willing to provide informed consent to the study. 
 
The following exclusion criteria were therefore applied:  
 outside the range of 18-49 years of age; 
 those who had been on ART for less than one year; 
 those who were unable or unwilling to provide informed consent, including 
those patients with mental health problems. 
 
3.6 Data Collection Tools 
 
Data collection tools were used in this study to meet its objectives, the participant 
questionnaire to collect data and clinic medical records checked to confirm ART 
adherence . The primary data collection instrument was a semi-structured questionnaire 
developed by the researcher, based on previous examples used by Langlois-Klassen et 




This tool was used to address the following objectives; determining the prevalence of 
African traditional medicines use in patients who are on antiretroviral therapy provided 
by Northdale Hospital, identifying which African traditional medicines are most 
commonly used by the patients, describing patients‟ perceptions about the 
effectiveness and the safety of the traditional medicines in this setting, investigating 
factors associated with the use of African traditional medicines by patients on 
antiretroviral therapy and comparing the level of adherence to ART amongst traditional 
medicine users and non-users as well as comparing the participants‟ responses with the 
data collected from their case files regarding ART adherence.  
The questionnaire was translated into the local language (isiZulu) by the researcher, 
who is a native speaker of the language. The translation was also verified by a second 
native speaker of isiZulu, who corrected any inconsistencies. The semi-structured 
questionnaire, with closed and open-ended questions, was used to obtain the following 
data: 
 Socio-demographic such as gender, age, marital status, ethnicity, religion, 
educational level and number of children. 
 Background and beliefs about traditional medicine use such as use of TM, 
reasons for using TM, type of TM used, beliefs about efficacy of TM 
especially on treating HIV, beliefs about safety of TM as well as its side 
effects. 
 Factors that could be associated with the decision to consult with a traditional 
healer included such as educational level, a lack of support, alcohol abuse, 
lack of knowledge about ART. 
 Impact of traditional medicine use on adherence to antiretroviral therapy: such 
as missing ART doses or stopping ART.  
Clinic medical records were checked to determine the ART adherence recorded after 
patient consultations. 
 
3.6.1 Pilot study  
 
Pilot testing of the questionnaire was completed at the study site with 5 persons living 
with HIV-infected aged 18-49 years who were not involved in the study. 
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 Information obtained from the pilot study was used to determine the user-friendliness 
of its contents and the time needed for completion. The information obtained was used 




3.7 Measures taken to reduce bias 
 
Measures taken to reduce potential bias were focused on selection and recall bias, as 
well as potential confounders. 
 
Selection bias 
In the absence of a sampling frame which would have allowed for a random sample of 
patients from all of those accessing ART at the facility, it was decided to use 
systematic sampling,  with every 3rd participant being selected. The date on which 
selection commenced was not unusual in any way, and the patients approached for 




As people are often not able to recall details accurately, it was important to use the 
clinic records to obtain data on adherence. Patients were informed that this information 
would be obtained from their clinic records before they gave consent to participate.  
 
Possible confounders 
The potential confounders, factors that could distort the relationship between exposure 
and outcome, were identified as: 
 Factors that could be associated with the decision to consult with a traditional 




 Factors that could be associated with non-adherence, such as alcohol abuse, 
depression, a lack of support, lack of knowledge about ART, cost, negative 
side-effects, stigma, and poor supply of medication.  
 
Data on these possible confounders were therefore included in the questionnaire design 
and incorporated into the statistical analysis.  
 
3.8 Data Collection Process 
 
Over a period of two days, 80 patients who were sitting in the queue to see the 
facility‟s pharmacy were approached to participate by the researcher.  This was done 
by using systematic sampling and approaching every third person sitting in the waiting 
queue. Potential participants were given information about the study both verbally and 
in writing, and were requested to provide written informed consent before being 
enrolled. They were assured that they would not lose their place in the waiting queue, 
nor would they be penalized should they decide not to participate.  Participants were 
individually interviewed in a private consultation room adjacent to the ARV pharmacy 
in the ARV clinic, with each interview taking approximately 10-15 minutes. After the 
interviews had been completed, the relevant clinic files were requested from the 
pharmacy to obtain their clinical records.  
 
3.8.1 Data Management  
 
The completed questionnaires were kept in a lockable cabinet in the researcher‟s 
residence. The digital data were kept on the researcher‟s computer, and a backup 
maintained. Data were provided in electronic format to the statistician.  The data will 







3.9 Data Analysis 
 
Quantitative data from the questionnaire were captured directly into the Statistical 
Package for Social Sciences (SPSS 21, Armonk, NY).  The data from the closed-ended 
questions on the questionnaire and the clinical records was first summarized and 
analyzed using descriptive statistics, namely frequency, percentage, and mean. The test 
statistic used was the two-sided Fisher's exact test. The significance level of the test 
was pre-specified at α= 0.05. The independent variables were expressed as frequencies 
and percentages, in a descriptive analysis. Participants‟ age and number of children 
were expressed as numerical variables, while gender, marital status, education level, 
ethnicity and religion were expressed as categorical variables. The strength of 
association between reported traditional medicine use and non-adherence was assessed. 
The significance of such associations was assessed using Pearson‟s chi-square test.  
Thereafter, binary logistic regression analysis was used to control for the effects of 




3.10 Ethical Considerations and Confidentiality 
 
The following ethical considerations were observed:  
 The research protocol was approved by the Post-Graduate Education Committee 
(Appendix B) and the Biomedical Research Ethics Committee of the University 
of KwaZulu-Natal (BE193/010; Appendix C). 
 Permission to conduct this study at Northdale Hospital was also obtained from 
the hospital manager (Appendix D). 
 All participants were provided with the information verbally as well as in 
writing, and each being required to sign the consent form before entering the 
study (Appendix E).  
 Participation in the study was strictly on a voluntarily basis. No participants were 
identified by name during the survey or in any records created for the study. All 
information obtained was kept confidential. 
 This study was conducted in compliance with the principles included in the 




In order to achieve the study objectives, data were collected from the study participants 
using a semi-structured questionnaire, while the clinic files were requested from the 
pharmacy to obtain the clinical records to obtain data on ART adherence. This enabled 
a comparison of information obtained from medical records with the data collected 
using the questionnaire.  
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CHAPTER 4: RESULTS 
 
4.1 Introduction  
 
This study was undertaken to establish the extent of use of traditional medicines in 
patients who are on antiretroviral therapy, as well as how this impacts on their 
adherence to medication. The results are presented with respect to the first five study 
objectives, the data being obtained from a questionnaire survey of patients attending 
Northdale Hospital in Pietermaritzburg. 
 
The specific objectives were: 
 To describe the prevalence of African traditional medicines use in patients who 
are on antiretroviral therapy provided by Northdale Hospital. 
 To identify which African traditional medicines are most commonly used by 
the patients. 
 To describe the patients perceptions about the effectiveness and safety of 
traditional medicines in this setting. 
 To investigate factors associated with the use of African traditional medicines 
by patients on antiretroviral therapy.  
 To compare the level of adherence to ART amongst users and non-users of 
African traditional medicines, as recorded by the Northdale ARV pharmacy. 
  
4.2. Socio-demographic characteristics  
 
As shown in Table 4.1, the majority of respondents were females (56/75; 75%), with a 
mean age of 33.9 years (SD: 7.1 years; range 20 to 49 years). The majority of the study 
participants were single (44/75; 58.7%), with 21.3% (16/75) being married, 9.3% 
(7/75) cohabiting (that is, living together but not formally married), 8% (6/75) 
widowed and 2.7% (2/75; 2.7%) being divorced. Most participants were Black 
Africans (71/75; 94.7%), with only a few self-identifying as Coloured (2/75; 2.7%) or 




The distribution of self-reported religious affiliation of the respondents showed that the 
overwhelming majority considered themselves to be Christians (63/75; 84%), with 
only a few reporting to follow the Shembe religion (7/75; 9.3%) or Hindu (1/75; 1.3%) 
faiths. Four respondents chose to report their religious affiliation as “other” (4/75; 
5.3%). The highest attained educational level reported was, primary education (33/75; 
44%), followed by secondary level education (28/75; 37.3 %). Only a few reported 
having completed tertiary level education (9/75; 12%), and five of the 75 respondents 
(6.7%) reported having no education at all. Only 14/75 respondents (18.7%) reported 
having no children, with the majority (53.2%) having either one or two children, and 




Table 4.1: Demographic details (n=75) 
 
Variable Characteristic No. % 
Gender Male 21 25.0 
Female 56 75.0 
Age 20 – 24 6 8.0 
25 – 29 20 26.6 
30 – 34 14 18.6 
35 – 39 17 22.6 
40 – 44 13 17.3 
45 – 49 5 6.6 
Marital status Single 44 58.6 
Married 16 21.3 
Widowed 6 8.0 
Divorced 2 2.6 
Cohabiting  7 9.3 
Ethnicity/ race Black African 71 94.6 
Coloured 2 2.6 
Indian 1 1.3 
White 0 0 
18 Other 1 1.3 
Religion 
 
Christian 63 84 
Hindu 1 1.3 
Shembe 7 9.3 
Muslim 0 0 
Other 1 1.3 
Highest attained education 
level 
Primary 33 44.0 
Secondary 28 37.3 
Tertiary 9 12.0 
No education 5 6.6 
 
Number of children 
0 14 18.7 
1 25 33.3 
2 15 20.0 
3 9 12.0 
4 4 5.3 
5 3 4.0 
6 4 5.3 
9 1 1.3 
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4.3 Prevalence of African traditional medicines use in patients who 
are on ART provided by Northdale Hospital 
 
Of the 75 study participants who were asked if they had used traditional medicines in 
the 28 days preceding the survey, only 9.3% (7/75) reported having done so as shown 
in Table 4.2. However, almost half of those taking traditional medicine indicated that 
they had missed doses of ART.  
 
Table 4.2: Traditional medicine use by participants 
 Yes  No 
No. (%) No. (%) 
Use of traditional medicine in the past 28 days 7 (9.3%) 68 (90.7%) 
Any ART missed doses due to traditional medicine use 3 (4.0%) 72 (96.0%) 
 
4.4 African traditional medicines most commonly used by the patients 
 
The types of African traditional medicine reported as having been used previously by 
the study participants were Intelezi (2/75; 2.7%), Imbiza (1/75; 1.3%), Imbiza herbal 
tonic (1/75; 1.3%), vomit inducer (1/75; 1.3%), and umuthi omhlophe (1/75; 1.3%). In 
addition, one participant (1.3%) reported the use of an un-named traditional medicine 
(Table 4.3). 
 
Table 4.3: Type of Traditional Medicine used by participants 
Type of Traditional medicine used No. Percent 
Intelezi 2 2.7 
Imbiza 1 1.3 
Imbiza herbal tonic 1 1.3 
Vomit inducer 1 1.3 
Umuthi omhlophe (White medicine) 1 1.3 




Although the majority of participants (68/75; 90.7%) did not report having used 
traditional medicines, those who did (7/75; 9.3%) provided a number of reasons for 
their use, including both health and cultural factors (Table 4.4). 
 
Table 4.4: Reasons for using traditional medicine by participants 
Reasons for using traditional medicines No. Percent 
Indiki (Temporal spirit possession of godfather) 1 1.3 
General cleansing purposes 1 1.3 
Cleansing purpose after death of a family member 1 1.3 
Cleansing the body 1 1.3 
Cultural function 1 1.3 
Protection against bewitching 1 1.3 
To win a court case 1 1.3 
Total 7 9.3 
 
4.5 Patients’ perceptions about the effectiveness and safety of 
traditional medicines  
 
Almost half of the participants (36/75; 48%) strongly disagreed that traditional 
medicines were effective in controlling HIV infection, as indicated in Figure 4.1. 
 
 





Table 4.5 summarises the participants‟ beliefs about the safety of traditional medicines. 
The majority of respondents (56/75; 74.6%) did not believe that traditional medicines 
were safe to use, while 25.3% (19/75) felt that they were safe. Almost half (37/75; 
49%) of the participants believed that traditional medicines were associated with 
adverse (side) effects. 
 
Table 4.5: Participants’ belief about safety of traditional medicines (n=75) 
 Yes  No 
No. (%) No. (%) 
Do you believe that it is safe to use traditional medicines? 19 (25.3%) 56 (74.7%) 
Do you believe that traditional medicine have side effects 37 (49.3%) 38 (50.7%) 
 
4.6 Factors associated with the use of African traditional medicines by 
patients on ART  
 
All of the participants (7/75) who admitted to having previously used traditional 
medicines were Black African males. Most of these respondents were single (57.1%; 
n=4/7), as shown in Table 4.6. 
 
Table 4.6: Marital status of participants who used traditional medicines (n=7) 
Marital Status No. % 
Single 4 57.1 
Married 1 14.3 
Widowed 1 14.3 
Cohabit 1 14.3 
Divorced 0 0 
Total 7 100 
 
The majority of participants who took traditional medicines followed the Christian 




Table 4.7: Religion of participants that used traditional medicines (n=7) 
Religion No. % 
Christian 5 71.4 
Shembe 2 28.6 
Hindu 0 0 
Muslim 0 0 
Other 0 0 
Total 7 100 
 
In terms of educational level, three of the participants who consumed traditional 
medicines had secondary level of education (42.9%, n=3/7), followed by two who had 
primary (28.6%, n=2/7), and one each who had tertiary (14.3%; n=1/7) and no 
education (14.3%; n=1/7). The distribution is depicted in Figure 4.2. 
 
 
Figure 4.2: Educational level for participants who reported using traditional 
medicine and ART concomitantly 
 
4.7 Level of adherence to ART amongst users and non-users of African 
traditional medicines, as recorded by the Northdale ARV pharmacy 
 
The adherence measure for the whole sample showed that 20% (n=15) of participants 





Table 4.8 summarizes the impact of ATM use on adherence and shows that out of the 
seven individuals that had used traditional medicines, three (42.9%) had missed ART 
doses (i.e. 3/7*100=42.9%) and that out of the 68 participants who had not used 
traditional medicines, 12 had missed their ART doses (i.e. 12/68*100=17.7%), 
therefore 17.7% is the proportion of participants that were not using traditional 
medicines but skipped some of their ART medicines doses. The null hypothesis was 
that the use of traditional medicines has a negative effect on ART adherence. Test for 
proportion was used to calculate the difference between the proportion of ATM users 
and non-ATM users who had missed ART. On the basis of Chi-square test, p=0.545 
and Chi-square= 0.366 therefore indicates that the findings were not statistically 
significant. 
 
Table 4.8: Antiretroviral doses missed by users and non-users of traditional 
medicines   
Missed ART doses ATM users Non-ATM users 
No. % No. % 
Yes 3 42.9 12 17.7 
No 4 57.1 56 82.3 
TOTAL 7 100 68 100 
 
For the purposes of this study, non-adherence was defined as missing three or more 
doses of antiretroviral treatment in a period of one month. Table 4.9 shows that, of the 
seven individuals who reported having used African traditional medicines, only one 
(1/7; 14.3%) missed more than three doses of ART in the month preceding the study. 
Of the remaining 68 participants who reported not having used African traditional 
medicines, five (5/68; 7.4%) of the 12 who had missed their ART had missed more 
than three ART doses during the same period. The difference in non-adherence 
between users and non-users of African traditional medicines was not statistically 
significant, whether tested by means of a two-sided Fisher's exact test (p=0.522) or a 
Chi-squared test (p= 0.41). 
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Table 4.9: Adherence status of traditional medicine users and non-users  
Adherence status ATM users Non-ATM users 
No. % No. % 
Adherent participants 6 85.7 63 92.6 
Non-adherent participants 1 14.3 5 7.4 
TOTAL 7 100 68 100 
However, based on multivariate logistic regression; using the backward Wald 
(elimination) method, male sex and the use of traditional medicines were identified as 
variables that significantly predicted the likelihood of an individual missing at least 3 
doses of ART (Table 4.10).  
 





Based on the questionnaires administered to 75 patients receiving ART at Northdale 
Hospital in Pietermaritzburg, and self-reported use of African traditional medicines, as 
well as assessment of adherence to ART, male sex and the use of African traditional 
medicines were shown to be associated with poor adherence (missing at least 3 doses 
of ART in a month).  
Variable P value 
Sex (male) 0.005* 
Age 0.205 
Marital status 0.488 
Ethnicity 0.689 
Religion 0.485 
Traditional medicine use in 
the past 28 days 
<0.0001* 
Overall statistics <0.0001 
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This Chapter provides a discussion of the findings presented in the preceding chapter 
and places them in the context of the available literature on traditional medicine use by 
patients who antiretroviral therapy and on the effect of such concomitant use on 
adherence to ART.  
 
5.2. The extent of use of ATM by patients on ART 
 
The available literature, as reviewed in Chapter 2, shows that ATM has been reported 
to be widely used in Africa, as is the case with traditional, complementary and 
alternative medicines in many other countries. The reasons for the use of traditional 
medicines vary considerably, including by those who are also receiving ART. The 
available literature points to a combination of factors such as, cultural and religious 
beliefs, a desire to alleviate ART side effects, to achieve additional efficacy in 
suppressing the virus and managing HIV disease, to improve their quality of life. 
However, there is also evidence that points to a potentially far lower prevalence of use 
of ATM by South Africans. Each year, Statistics South Africa conducts the General 
Household Survey among a nationally-representative sample of the population 
(Statistics South Africa, 2015). The 2015 survey was conducted among residents of 
private households in all nine provinces of South Africa as well as workers‟ hostels. It 
does not include those living in other collective living quarters, such as students‟ 
hostels, old-age homes, hospitals, prisons and military barracks. One of the standard 
question posed is about the type of health care facility consulted first by households 
when a household member fall ills or has an accident. In 2015, only 0.5% of 
respondents indicated that they would first seek help from a traditional healer 
(Statistics South Africa, 2015; 23). That figure has remained remarkably stable since 
2004, varying from a low of 0.1% in 2011 and 2013 to a high of 0.6% in 2005 
(Statistics South Africa, 2015). The key element maybe the way the question is posed. 
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 While many South Africans may not “first” seek help from a traditional healer, they 
may still use ATM in addition to Western medicines at some stage in the process of 
care, such as during chronic ART. 
 
The prevalence of ATM use among patients on ART at Northdale Hospital in 
Pietermaritzburg was found to be lower than was initially expected (7/75 participants; 
9.3%). However, this finding may be an underestimate of the true prevalence, either 
due to the small sample size and/or social desirability bias. The data were based on 
self-reports elicited by a pharmacist in a hospital setting where traditional medicine use 
alongside ART is usually discouraged. Previous surveys showed a higher prevalence of 
various types of TM by patients receiving ART. For example, Namudduet al. (2011) 
showed that one in every three patients (33.7%) on ART in Uganda used traditional 
medicines at the same time. Hughes et al. (2012) showed that 16% of participants on 
ART reported TM use. Lubinga et al. (2012) reported that 46.4% of participants in 
their study were using TM in addition to ART. Mudzviti et al. (2012) found that 98.2% 
of participants in a site in Zimbabwe were using at least one herbal medicine together 
with ART. The use of traditional medicines was also evident in settings other than 
those in Africa. Knippels and Weiss (2000) found that 71% of HIV-positive Dutch gay 
men used at least one alternative therapy since first receiving notification of HIV 
serostatus, alone or in combination with other medicines. 
 
As identified in a systematic review by Rachlis et al. (2011), social factors such as 
marital status and having children can impact on ART adherence. Wasti et al. (2012) 
published a systematic review of factors influencing adherence to ART, but 
specifically in Asian developing countries. They identified the factors impeding 
adherence to ART as socio-cultural, financial, health system and drug-related factors. 
Age, sex, marital status, religion and educational level were therefore selected as 
potential predictors of traditional medicine use in this study. All of the participants 
who admitted to-having used traditional medicines were Black African males (7/7; 
100%). The majority (4/7; 57.1%) were single, and 5/7 (71.4%) followed a Christian 





The mean age of the participants in the current study (33.9 years) was comparable to 
that of the participants in the study conducted by Langlois-Klassenet al. (2007; 36 
years), Mudzvitiet al. (2012; 40.8 years), Hughes et al. (2012; 37 years, Malangu 
(2007; 36.7), and Namudduet al. (2011; 39 years). Hughes et al. (2012) showed that 
traditional medicine use was more common in an older age group (38-62 years; 17.4%) 
than in a younger age group (19-37 years; 13.7%); n=7). However, in the present 
study, no significant relationship was found between age and use of traditional 
medicine (p=0.205). 
 
The majority of participants in the present study were females (54/75; 72%), which 
was also consistent with previous surveys conducted in African settings. Malangu 
(2007) included 68.9% females, Langlois- Klassen et al. (2007) reported on 70.1% 
females, Mudzviti et al. (2012) showed 64.7% females, and Hughes et al. (2012) 
70.1% females. This is important as all participants in the present study who self-
reported having used traditional medicines in the preceding 28 days were males. By 
contrast, Langlois-Klassen et al. (2007) showed that concurrent use of traditional 
herbal medicine and pharmaceutical medicines was statistically significantly more 
common among female respondents (34.7%) compared to male respondents (17.1%; 
p= 0.038). This finding was also reported by Hughes et al. (2012), although the 
number of traditional medicine users was small (11 female and 4 male). Namuddu et 
al. (2011) also found that TM use was higher among women (36.4%) compared to men 
(27.3%). However, given the small number of participants in the current study who 
self-reported using ATM (n=7), this finding should not be over-emphasised. As in 
many African settings, the majority of patients on ART in South African public sector 
facilities are women, reflecting not only the effects of differential health-seeking 
behaviour and stigma, but also the impact of antenatal care and testing. Given the 
setting for the present, study, the inclusion of a majority of black Africans participants 
was not surprising. The role of ethnicity was not explored in other studies conducted in 
an African setting, though Langlois-Klassen et al. (2012) did report on tribal identity.  
 
In the present study, the majority of participants (58.7%) were single, which was 
comparable to the figures reported by Malangu (2007; 77.8%). Hughes et al. (2012) 
found that the majority of participants (73.2%) in their study were never married. 
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However, Langlois-Klassen et al. (2007) reported that the largest proportion of study 
participants (42.3%) was married. Namuddu et al. (2011) showed that single 
individuals were more likely to use TM compared to married individuals (p=0.006), 
and those older than 39 years were less likely to use TM than those who were less than 
38 years (p=0.002).  
 
Hughes et al. (2012) reported that participants were more likely to use TM if they were 
from a rural province, female, older, unmarried, employed and had limited education. 
In the present study, marital status was not a statistically significant predictors of 
traditional medicine use and non-adherence to ART (p=0.488). 
 
Most participants in the present study (33/75; 44%) had achieved no more than a 
primary level of education. Hughes et al. (2012) showed a similar picture, where the 
majority (73.2%) had less than high school education. Langlois-Klassen et al. (2007) 
also drew from a similar sample, where the majority (57.7%) had no more than a 
primary school education, as did Namuddu et al (2011; 50.9%). The participants in the 
study conducted by Malangu (2007) were more highly educated, with 73.9% having 
reached high school education. Hughes et al. (2012) showed that traditional medicines 
were used to a greater extent by those who had no schooling (31.3%) compared to 
those who had some education (12.4%). Although the numbers are probably too small 
to draw any conclusions, in the present study traditional medicines were used by 
participants who had secondary level of education (3/7; 42.9%), primary education 
(2/7; 28.6%), tertiary (14.3%; n=1/7) and no education at all (1/7; 14.3%).  
 
In the present study, the majority of participants (81.3%) reporting having had 
children. In the study conducted by Hughes et al. (2012), 83.5% of participants 
reported having children, and traditional medicine use was more common amongst 
these participants (17.1%) than among those who reporting having no children (6.3%). 






5.3 African traditional medicines used and reasons for use 
 
Several studies in the literature have reported a variety of traditional medicines used by 
patients who are on ART.  In the present study the majority (68/75; 90.7%) denied any 
use of traditional medicine. Drawing too many conclusions from the small number of 
study participants (7/75; 9.3%) who self-reported using traditional medicine while on 
ART is therefore not recommended.  
 
The compositions of most traditional medicine mixtures are not specified to users by 
traditional health practitioners or sellers of such products. Some participants therefore 
did not know the names of traditional medicines they were using, and in some cases, 
only the indication for use could be reported. This made it difficult to compare the 
types of ATMs reported to be used in the present study and to compare these with the 
ATMs reported in other surveys. The traditional medicine used by study participants 
were described as Intelezi (2/75; 2.7%), Imbiza (1/75; 1.3%), Imbiza herbal tonic (1/75; 
1.3%), vomit inducer (1/75; 1.3%), umuthiomhlophe (white medicine) (1/75; 1.3%). In 
addition, one user (1/75; 1.3%) did not know the names of the traditional medicines he 
had used. Babb et al.  (2007) reported that, in their study, the frequently-used products 
were African potato plant (Hypoxisrooperi) and kgala (Aloe vera). In stark contrast, 
though, Hughes et al. (2012) reported that the most popular ATM was a herbal mixture 
described as ubhejane. Malangu (2007) reported the use of African potato 
(Hypoxishemerocallidea) and coconut (Cocosnucifera), but also of unspecified 
traditional mixtures. Namudduet al. (2011) described the use of locally mixed stems, 
wood barks, leaves, food supplements and individual morning urine. Mudzviti et al. 
(2012), who conducted their study in a Zimbabwean setting, described the use of 
Allium sativum (72.7%), Bidens pilosa (66.0%), Eucalyptus globulus (52.3%), 








The reasons for use can be an illumination of the listed ingredients. With the usual 
caveat that the number of reported users was low, the present study participants listed 
general cleansing purposes (1/75; 1.3%), cleansing purposes (1/75; 1.3%), cleansing 
after death of a family member (1/75; 1.3%), cleansing of the body (1/75; 1.3%, 
cultural functions including cleansing purposes (1/75; 1.3%), protection against 
bewitching (1/75; 1.3%) and use in order to win a court case (1/75; 1.3%). 
It is clear that these reasons can be more generally grouped as relating to “cleansing” 
(perhaps for cultural reasons) and for uses related to traditional beliefs (such as in the 
role of “bewitching” as a cause of disease or bad luck). Truter (2007) reported the 
reasons for traditional medicine use as to be: “know healers quite well”, “visits not 
only for health problems but also for other problems”, and “belief that illness arises 
from supernatural causes”. Participants in a survey by Hughes et al. (2012) indicated 
that they had used traditional medicine to gain strength, increase their appetite, and 
relieve symptoms of numbness, ulcers and bad dreams. Similarly, Langlois-Klassen et 
al. (2007) reported that the predominant reason for traditional herbal medicine use by 
patients receiving ART was that they wanted relief from the symptoms they 
experienced. The most common reasons given for their use in the study performed by 
Langlois-Klassen et al. (2007) were, in descending order of frequency: availability of 
traditional medicine (32.6%), traditional medicine effectiveness (14.6%), proximity of 
herbs to the patient (16.3%), familiarity with traditional medicine (10.9%), and 
affordability (9.3%). Namuddu et al. (2011) also recorded reasons related to the relief 
of symptoms, such as to reduce constant fever (67.4%) and treat cough (65.2%).  
 
Almost half of the participants in the present study (36/75; 48%) did not agree with the 
statement that traditional medicines were effective in controlling HIV infection. 
However all the participants who self-reported having used traditional medicine 
indicated that had helped them in some way. This finding is broadly in concert with 
those reported elsewhere. Babb et al. (2007) reported that 86% of participants in their 
study who were using traditional medicines felt that they made their health „better‟ or 





In a study done by Langlois-Klassen et al. (2007), they found that 14.6% of 
participants believed in traditional medicines‟ effectiveness. Simon et al. (2010) 
looked at the preparation for ART rollout in rural South Africa and found that 73% of 
respondents believed that ART works better than TM, and that 56% thought it was not 
safe to use ART concomittantly with TM. Namuddu et al. (2011) reported that 96.3% 
of patients on ART who reported using TM perceived better health and that those who 
reported side effects from ART were two times more likely to use TM compared to 
those who did not.-In the present study, few of the participants (20/75; 26.7%) believed 
that it was safe to use traditional medicines. Accordingly, almost half (37/75; 49%) 
believed that traditional medicines were associated with adverse (side) effects. This 
may well the consequence of conditioning by the hospital health workers, or reflect 
potential social desirability bias. For example, Babb et al. (2007) reported that users 
tolerated traditional medicines well and that none felt that they had side effects. 
 
5.4 Impact of traditional medicine use on adherence to antiretroviral 
therapy 
 
The aim of the present study was to examine whether use of ATM was associated with 
decreased adherence to ART. However, as very few of the study participants (7/75; 
9.3%) admitted to having used ATM concurrently with ART, drawing any conclusions 
from these data is difficult. The results indicated that, of the seven individuals who 
reported using traditional medicines, three (42.9%) also reported having missed ART 
doses. Nonetheless, the bivariate analysis indicated that the variables that were 
significantly associated with non-adherence to ART were traditional medicine use and 
male sex (p=0.005) and the use of traditional medicines (p<0.0001).  
 
Owen-Smith et al. (2007) investigated the relationship between complementary/ 
alternative medicine (CAM) use and ART adherence and found that women using 
CAM, relative to non-CAM users were 1.69 (95% CI: 1.01-2.80; p=0.41) times more 
likely to report missing ART doses in the preceding 30 days, even after adjusting for 





This finding was previously reported in South Africa, where Peltzer et al. (2010) found 
that, based on multivariate analysis regression analyses, ARV non-adherence (in 
relation to dose, schedule and food) was associated with the use of herbal treatment, 
but not with taking micronutrients or using  non-prescription medicines. Namuddu et 
al. (2011) reported that patients whose adherence level was below 95% were more 
likely to use traditional medicine. However, the relationship between traditional 
medicines use and reduced ART adherence has not always been detected. Lubinga et 
al. (2012) found that widespread concomitant herbal medicines had no association with 
poor ART adherence in a Ugandan setting (OR 0.85;  95% CI; 0.47-1.53).  
 
The relationship has also not held true in non-African settings. Knippels and Weiss 
(2000) investigated the use of alternative medicine in a sample of Dutch HIV-positive 
gay men, and reported that users had better adherence to ART than non-users. 
However, such a finding may be the result of a confounding variable, such as greater 
concern about health and well-being among users of alternative medicines that among 
non-users. Those with greater concern about health and well-being may be more 




Although the present study did confirm the relationship between concomitant use of 
ATM and poor adherence to ART, the data did present a number of important 
limitations. Few conclusive findings can be extracted with any confidence from such a 
small sample of concurrent users. Nonetheless, the potential interaction between ATM 
use and ART, either at the level of potential pharmacological or pharmacokinetic drug-
drug interactions or at the level of effects on adherence and health-seeking behaviour, 
cannot be ignored. Recommendations for practice are accordingly offered in the next 
chapter. Although the extent of concurrent use may appear low, this may be an under-
estimate of the true prevalence of ATM use by patients who are receiving ART. Social 
desirability bias, or the impact of instrument design may, as is seen in the annual 





The reasons for ATM use are often as much cultural and health-related, and are 
therefore unlikely to be avoided by simple admonitions not to co-administer such 
treatments. The evidence gathered in other settings, particularly in African countries, 
cannot be ignored. 
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CHAPTER 6: CONCLUSION AND RECOMMENDATIONS 
 
6.1 Introduction  
 
The primary motivation for conducting this study was that there is limited information 
about the use of traditional medicine among patients receiving ART in South Africa. 
There were reasons to believe that this was a common practice, but little was known 
about how and why ATM was used, and how its use might affect adherence to ART, a 
key determinant of patient outcomes. A particular concern was that the use of 
traditional medicine might be associated with increased non-adherence to ART. This 
Chapter discusses the significance as well as the conclusion and recommendations 
based on the findings of the study.  
 
6.2 Significance of the study 
 
Although only 9.3% of participants admitted to have used traditional medicines in this 
the survey, this indicates that there is still minority of patients that use traditional 
medicines and ART together.  It is crucial that continued patient counseling regarding 
medication such as dangers of drug-drug interactions are discussed and reinforcement 
of adherence to ART at every clinic visit is emphasised. Another interesting finding 
was that participants did not seem have enough knowledge about the types of the 
traditional medicines they were using. This indicates the importance of strengthening 
the relationship between traditional health practitioners and the formal health sector. 
This can be achieved, for example, by including traditional health practitioners on 
hospital boards or clinic committees, and by creating opportunities for contact between 
such practitioners and health professionals such as medical practitioners, nurses and 





6.3 Study limitations 
 
Despite previous studies having shown far higher prevalence of concomitant ATM use 
with ART, the present study identified only a small number of participants (all African 
males) who reported missing ARV doses and who also self-reported traditional 
medicine use. A major limitation of this study was that it was cross-sectional, and 
therefore captured only a “moment in time”. Ideally adherence patterns to any 
treatment should be tracked over a sustained period of time. In addition, social 
desirability bias could not be eliminated entirely, even though the researcher was non-
judgmental and able to engage participants as an African. Nonetheless, the effect of 
being asked about a practice that is actively discouraged in the health care setting 
cannot be ignored. Recall bias can also not be excluded. Due to the small sample size, 
the results may not generalizable to all patients who attend ART clinics in the public 




Accordingly, the following recommendations are offered: 
 Healthcare providers should routinely screen patients for traditional medicine 
use when initiating antiretroviral therapy and also during follow-up and 
monitoring, keeping in mind that these patients may not fully disclose all 
medicines or therapies that they are using. It is imperative that a non-
judgmental approach is used, implicitly giving patients the space to be open and 
honest about their health-seeking behaviour, and about the full range of 
practitioners and practices they may have consulted and used or may plan to 
consult or use. This should, hopefully counter the potential impact of social 
desirability bias in the responses provided, and thus the completeness of the 
data on which clinical decisions can be made. Pharmacists can play a key role 
being the interface between ART prescriptions and patient access, their 
knowledge about medicines formulations can assist patients in understanding 





 A strengthened relationship between traditional health practitioners and the 
formal health sector must be fostered. In this regard, the full implementation of 
the Traditional Health Practitioners Act (Act 35 of 2004) must receive 
attention, so as to effectively regulate both training and practice. 
 
 Further studies, utilising larger and more diverse samples and longitudinal 
designs are required to give a more accurate estimate of the true prevalence of 
traditional medicine use among patients already on antiretroviral therapy, as 






In the present study, only 9.3% of participants admitted to having used traditional 
medicines in the 28 days preceding the survey. Nonetheless, participants were more 
likely to be non-adherent to ART if they were male and self-reported using traditional 
medicine. This finding, which broadly supports those generated elsewhere in African 
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Traditional medicine use questionnaire 





b. Age: ……years 


































g. Number of children:__________ 
 
2. Use of traditional medicines 
a. Do you believe that ART has helped you in any way? please 
explain.________________________________________________
_______________________________________________________ 
b. In your own terms, how would you define ART? 
_______________________________________________________
_______________________________________________________ 
c. For how long have you been on ART? 
____________________ 
d. 'ART is effective in controlling HIV infection' 
Strongly agree  
Mildly agree  
Mildly disagree  
Strongly disagree  
Do not know  
 
e. Do you it is safe to use ART? Please explain. 
_______________________________________________________
_______________________________________________________ 








g. If yes, how did you handle them? 
_______________________________________________________
_______________________________________________________ 
h. What brought you to the clinic for ART? 
_______________________________________________________
_______________________________________________________ 
i. Do you have enough support from your partner, family or friends 
regarding HIV and ART? 
Yes  
No  
j. In the past 28 days did you miss any antiretroviral medicine doses 




k. If yes, how many doses of ARVs did you miss? 
Less than 3  
More than 3  




m. Who/ what introduced you to traditional medicine use in your life? 
________________________________________ 
n. In the past 28 days, did you use any traditional medicine? 
Yes  
No  









p. What was the reason for using traditional medicine use? 
_______________________________________________________
_______________________________________________________ 
q. For how long did you use traditional medicine? ________________ 
r. What type of traditional medicine did you use? 
___________________________________________________ 




t. Do you believe that traditional medicine is effective in controlling 
HIV infection? 
Strongly agree  
Mildly agree  
Mildly disagree  
Strongly disagree  
Do not know  
 


















































































Study title:  
Traditional medicine use in patients on antiretroviral therapy (ART): A cross-sectional 





I, Zethu Mazibuko am doing research on the traditional medicine use by HIV-positive 
people on antiretroviral therapy during 2010. Research is just the process to learn the 
answer to a question. In this study we want to learn if traditional medicines use has any 
impact on adherence to ART. This is important to learn because anything that hinders 
adherence to ART is important to public health. This is a study involving research and 
not routine care.   
 
Invitation to participate:  I am asking / inviting you to participate in a research study. 
 
What is involved in the study – This is a descriptive cross-sectional study design, as a 
participant you will be requested to complete a questionnaire about the use of 
traditional medicines. The study is expected to cease on 30/11/2010. A sample of 75 
people will take part in the study, and all from South Africa. 
 
No risks are foreseen of being involved in the study. 
 
There are no potential benefits of being in the study.  
 
The participant will be given pertinent and appropriate information on the study while 
involved in the project and after the results are available. 
 
Participation is entirely voluntary, refusal to participate will involve no penalty or 
loss of benefits to which you are otherwise entitled, and you may discontinue 




No reimbursements will be provided for participating in this study 
Confidentiality: Every effort will be made to keep personal information confidential.  
Absolute confidentiality cannot be guaranteed.  Personal information may be disclosed 
if required by law. 
Organizations that may inspect and/or copy your research records for quality assurance 
and data analysis include groups such as the Biomedical Research Ethics Committee, 
Data Safety Monitoring Committee and the Medicines Control Council. 
If results are published, this will not lead to individual identification. 
  
 
Contact details of researcher/s – for further information / reporting of study related 
adverse events. 
Zethu Mazibuko 
Cell Number: 0829571712 
 
Contact details of BREC Administrator or Chair – for reporting of complaints/ 
problems: 
Biomedical Research Ethics, Research Office, UKZN, Private Bag X54001, 
Durban 4000 
Telephone: +27 (0) 31 260 4769 / 260 1074 
Fax:   +27 (0) 31 260 4609 












My name is Zethu Mazibuko and I am a student at the University of KwaZulu Natal. I 
am in a process of doing a research about the use of traditional medicines by the people 
who are taking antiretroviral medicines. 
 
You have been asked to participate in a research study called: Traditional medicine use 
in patients on antiretroviral therapy (ART): A cross-sectional study at Thembalethu 
Wellness Centre in Northdale Hospital. Clinic medical records will be used to double 
check information collected by a questionnaire. 
 
You have been informed about the study by Zethu Mazibuko 
You may contact Zethu Mazibuko at 0829571712 any time if you have questions about 
the research or if you are injured as a result of the research. 
 
You may contact the Biomedical Research Ethics Office on 031-260 4769 or 
2601074 or Email BREC@ukzn.ac.za if you have questions about your rights as a 
research participant. 
 
Your participation in this research is voluntary, and you will not be penalized or lose 
benefits if you refuse to participate or decide to stop at any time. 
 
If you agree to participate, you will be given a signed copy of this document and the 








The research study, including the above information, has been described to me orally. I 
understand what my involvement in the study means and I voluntarily agree to 
participate. I have been given an opportunity to ask any questions that I might have 
about participation in the study. 
 
 
____________________      ____________________ 
Signature of Participant                            Date 
 
 
____________________   _____________________ 
Signature of Witness                                Date 
(Where applicable)      
 
 
____________________   _____________________ 
Signature of Translator                            Date 
(Where applicable) 
 
